We, for the first time identify UBE2Q1 as a potential prognostic marker for aggressive ovarian and breast cancers and predictive marker for platin/taxane chemotherapy in high grade serous ovarian carcinoma. The gene discussed is UBE2Q1; the disease is ovarian serous carcinoma.